CVR: 32657222
NOVO NORDISK PHARMA OPERATIONS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2009. The company is registered under the industry Formidlingsaktiviteter i forbindelse med specialiserede bygge- og anlægsarbejder. The management consists of Hanna Elisabet Høj. The company is owned by NOVO NORDISK REGION AAMEO AND LATAM A/S. In 2025, the company reported revenue of DKK 126,242,000 and a net result of DKK 1,955,000 compared with DKK 2,298,000 the year before. Equity amounted to DKK 33,422,000.
The financial health of NOVO NORDISK PHARMA OPERATIONS A/S appears stable, with a consistent revenue growth trend from 98.63 million DKK in 2021 to 126.24 million DKK in 2025. However, profit has fluctuated, peaking at 5.02 million DKK in 2023 before declining to 1.96 million DKK in 2025, indicating potential challenges in maintaining profitability. The company’s equity has shown a positive trajectory, increasing from 20.54 million DKK in 2021 to 33.42 million DKK in 2025, which strengthens its financial position. While the revenue growth is promising, the declining profit margins may raise concerns about operational efficiency and cost management within the specialized construction industry.
AI-generated summary
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at etablere og/eller besidde filialer og ejerandele i selskaber i ind- og udland, at foretage investerings- og finansieringsvirksomhed, herunder anbringelse af kapital i virksomheder og fast ejendom i ind- og udland samt efter bestyrelsens nærmere bestemmelse at servicere sådanne selskaber og virksomheder driftsmæssigt. Selskabets formål er tillige at understøtte Novo Nordisk A/S farmaceutiske aktivitet.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 126.2 mio. | 2 mio. | 92.2 mio. | 33.4 mio. | 103 | |
Compared to 68 companies in Formidlingsaktiviteter i forbindelse med specialiserede bygge- og anlægsarbejder
Comparison is based on industry median values
As of May 12, 2026, Hanna Elisabet Høj is registered as adm. dir. of NOVO NORDISK PHARMA OPERATIONS A/S.
As of May 12, 2026, Melanie Raouzeos-Haid has stepped down as adm. dir. of NOVO NORDISK PHARMA OPERATIONS A/S.
As of May 23, 2024, John Francis Kuckelman has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of May 23, 2024, Kristine Aachmann Bethe has left the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of June 30, 2023, Kristine Aachmann Bethe has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of June 30, 2023, Tomas Haagen has left the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of June 1, 2023, Lars Bo Smidt has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of June 1, 2023, Claus Steensen Sølje has left the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of June 1, 2023, Melanie Raouzeos-Haid is registered as adm. dir. of NOVO NORDISK PHARMA OPERATIONS A/S.
As of June 1, 2023, Lars Bo Smidt has stepped down as adm. dir. of NOVO NORDISK PHARMA OPERATIONS A/S.
As of May 12, 2021, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NOVO NORDISK PHARMA OPERATIONS A/S.
As of May 12, 2021, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NOVO NORDISK PHARMA OPERATIONS A/S.
As of December 15, 2020, Linette Tangsgaard Nielsen has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of December 15, 2020, Lene Moth Bang has left the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of August 13, 2020, Lars Bo Smidt is registered as adm. dir. of NOVO NORDISK PHARMA OPERATIONS A/S.
As of August 12, 2020, Lars Bo Smidt has stepped down as adm. dir. of NOVO NORDISK PHARMA OPERATIONS A/S.
As of October 1, 2018, Tomas Haagen has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of October 1, 2018, Ole Falvig Ramsby has left the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of April 25, 2018, Lene Moth Bang has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of April 25, 2018, Karsten Munk Knudsen has left the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of April 25, 2017, Claus Steensen Sølje has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of April 25, 2017, Anne Mette Wiis Vogelsang has left the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of April 25, 2017, Lars Bo Smidt is registered as adm. dir. of NOVO NORDISK PHARMA OPERATIONS A/S.
As of April 25, 2017, Claus Steensen Sølje has stepped down as adm. dir. of NOVO NORDISK PHARMA OPERATIONS A/S.
As of April 14, 2015, Anne Mette Wiis Vogelsang has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of April 14, 2015, Robert Janicki has left the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of July 1, 2014, Karsten Munk Knudsen has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of July 1, 2014, Lars Green has left the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of September 1, 2013, Claus Steensen Sølje is registered as adm. dir. of NOVO NORDISK PHARMA OPERATIONS A/S.
As of September 1, 2013, Peter Helt Jacobsen Haahr has stepped down as director of NOVO NORDISK PHARMA OPERATIONS A/S.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NOVO NORDISK PHARMA OPERATIONS A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of NOVO NORDISK PHARMA OPERATIONS A/S.
As of December 17, 2010, Peter Helt Jacobsen Haahr is registered as director of NOVO NORDISK PHARMA OPERATIONS A/S.
As of December 17, 2010, Leif Fenger Jensen has stepped down as director of NOVO NORDISK PHARMA OPERATIONS A/S.
As of December 18, 2009, A/S PSE NR. 4820 has been appointed auditor of NOVO NORDISK PHARMA OPERATIONS A/S.
As of December 18, 2009, Ole Falvig Ramsby has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of December 18, 2009, Lars Green has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of December 18, 2009, Robert Janicki has joined the board of directors of NOVO NORDISK PHARMA OPERATIONS A/S.
As of December 18, 2009, Leif Fenger Jensen is registered as director of NOVO NORDISK PHARMA OPERATIONS A/S.
As of December 18, 2009, NOVO NORDISK REGION AAMEO AND LATAM A/S is registered as an owner of NOVO NORDISK PHARMA OPERATIONS A/S with an ownership share of 100%.
NOVO NORDISK PHARMA OPERATIONS A/S was founded on December 18, 2009.
Companies in the same industry and area
CVR 43094807
CVR 35025081
CVR 44024152
CVR 46552318
CVR 33696167
companydata.dk